Abstract:Milbemycins A3/A4 are important 16-membered macrolides which have been commercialized and widely used as pesticide and veterinary medicine. However, similar to other milbemycin producers, the production of milbemycins A3/A4 in Streptomyces bingchenggensis is usually accompanied with undesired by-products such as C5-O-methylmilbemycins B2/B3 (α-class) and β1/β2 (β-class) together with nanchangmycin. In order to obtain high yield milbemycins A3/A4-producing strains that produce milbemycins A3/A4 as main components, milD, a putative C5-O-methyltransferase gene of S. bingchenggensis, was biofunctionally investigated by heterologous expression in Escherichia coli. Enzymatic analysis indicated that MilD can catalyze both α-class (A3/A4) and β-class milbemycins (β11) into C5-O-methylmilbemycins B2/B3 and β1, respectively, suggesting little effect of furan ring formed between C6 and C8a on the C5-O-methylation catalyzed by MilD. Deletion of milD gene resulted in the elimination of C5-O-methylmilbemycins B2/B3 and β1/β2 together with an increased yield of milbemycins A3/A4 in disruption strain BCJ13. Further disruption of the gene nanLD encoding loading module of polyketide synthase responsible for the biosynthesis of nanchangmycin led to strain BCJ36 that abolished the production of nanchangmycin. Importantly, mutant strain BCJ36 (∆milD∆nanLD) produced milbemycins A3/A4 as main secondary metabolites with a yield of 2312 ± 47 μg/ml, which was approximately 74 % higher than that of the initial strain S. bingchenggensis BC-109-6 (1326 ± 37 μg/ml).

A Novel Spiro-Heterocycle Milbemycin Metabolite from a Genetically Engineered Strain of Streptomyces Bingchenggensis.

Two New Milbemycin Derivatives from a Genetically Engineered Strain Streptomyces Bingchenggensis.

New Milbemycin Metabolites from the Genetically Engineered Strain Streptomyces Bingchenggensis Bcj60

Two New 5-Oxomilbemycins Possessing an Unusual 3,27-Epoxy Bond from the Genetically Engineered Strain Streptomyces Bingchenggensis BCJ60

Two novel milbemycin derivatives from the genetically engineered strain Streptomyces avermitilis AVE-H39

Two New Β-Class Milbemycins from Streptomyces Bingchenggensis: Fermentation, Isolation, Structure Elucidation and Biological Properties

New 5-Oxomilbemycins from A Genetically Engineered Strain Streptomyces Bingchenggensis Bcj60

Further new milbemycin antibiotics from Streptomyces bingchenggensis. Fermentation, isolation, structural elucidation and biological activities.

Two New 13-Hydroxylated Milbemycin Metabolites from the Genetically Engineered Strain Streptomyces Avermitilis AVE-H39

Characterization of a Pathway-Specific Activator of Milbemycin Biosynthesis and Improved Milbemycin Production by Its Overexpression in Streptomyces Bingchenggensis

The Mildiomycin Biosynthesis: Initial Steps for Sequential Generation of 5-Hydroxymethylcytidine 5′-Monophosphate and 5-Hydroxymethylcytosine in<i>Streptoverticillium rimofaciens</i>ZJU5119

New Macrocyclic Lactones with Acaricidal and Nematocidal Activities from a Genetically Engineered Strain Streptomyces Bingchenggensis BCJ60

Three new milbemycin derivatives from Streptomyces bingchenggensis.

A New Β-Class Milbemycin Derivative from a Mutant of Genetically Engineered Strain Streptomyces Avermitilis AVE-H39

Genetic Engineering of Streptomyces Bingchenggensis to Produce Milbemycins A3/A4 As Main Components and Eliminate the Biosynthesis of Nanchangmycin

Three new milbemycins from a genetically engineered strain S . avermitilis MHJ1011

Preliminary Study on Milbemycin Biosynthesis of Streptomyces Milbemycinicus DSM41911

New Milbemycins from Mutant Streptomyces Bingchenggensis X-4

Derivatives of Holomycin and Cyclopropaneacetic Acid from Streptomyces Sp Dt-A37

Design, Synthesis, and Biological Activities of Milbemycin Analogues

Genome sequence of the milbemycin-producing bacterium Streptomyces bingchenggensis.